Behavioral changes through technology-supported interventions could help reduce sodium intake and positively impact health.
Lilly’s oral cardio drug that blocks lipids passes mid-stage test
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS